High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
- Citation:
- Clin Cancer Res vol 24 (13) 3053-58
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 7
- Parents:
- 2745
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA025224 U10CA180790
- Corr. Author:
- Authors:
- Saranya Chumsri Jeff Sperinde Heshan Liu Joseph Gligorov Jean-Philippe Spano Martine Antoine Alvaro Moreno Aspitia Winston Tan John Winslow Christos J Petropoulos Ahmed Chenna Michael Bates Jodi Marie Weidler Weidong Huang Amylou Dueck Edith A. Perez
- Networks:
- LAPS-IL057, LAPS-MN026, PR028
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N0337, NCCTG-N98-32-52
- Phases:
- 2
- Keywords: